{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T23:28:57Z","timestamp":1648769337117},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pediatric Health Care"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.pedhc.2006.07.002","type":"journal-article","created":{"date-parts":[[2006,9,7]],"date-time":"2006-09-07T14:43:24Z","timestamp":1157640204000},"page":"342-349","source":"Crossref","is-referenced-by-count":2,"title":["Educating Teens About Vaccines"],"prefix":"10.1016","volume":"20","author":[{"given":"Georgianna","family":"Hernandez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Nestor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedhc.2006.07.002_bib1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00006250-200509000-00053","article-title":"Committee opinion: Meningococcal vaccination for adolescents","volume":"106","year":"2005","journal-title":"Obstetrics & Gynecology"},{"key":"10.1016\/j.pedhc.2006.07.002_bib2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1542\/peds.2005-1314","article-title":"Prevention and control of meningococcal disease: Recommendations for use of meningococcal vaccines in pediatric patients","volume":"116","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedhc.2006.07.002_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1542\/peds.2005-2790","article-title":"Policy statement: Recommended childhood and adolescent immunization schedule\u2014United States, 2006","volume":"117","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedhc.2006.07.002_bib4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.virol.2005.09.057","article-title":"New viral vaccines","volume":"344","author":"Arvin","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.pedhc.2006.07.002_bib5","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/01.inf.0000186296.52985.ba","article-title":"Immunization against genital human papillomavirus","volume":"24","author":"Bonnez","year":"2005","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1016\/j.pedhc.2006.07.002_bib5a","first-page":"658","article-title":"National, state and urban area vaccination coverage among children aged 19-35 months: United States, 2003","volume":"53","year":"2004","journal-title":"MMWR: Morbidity and Mortality Weekly Review"},{"key":"10.1016\/j.pedhc.2006.07.002_bib6","first-page":"1212","article-title":"Notice to readers: Licensure of a combined live attenuated measles, mumps, rubella, and varicella vaccine","volume":"54","year":"2005","journal-title":"MMWR: Morbidity and Mortality Weekly Review"},{"key":"10.1016\/j.pedhc.2006.07.002_bib7","series-title":"Vaccines for children program: Vaccines to prevent measles, mumps, rubella, and varicella","year":"2005"},{"key":"10.1016\/j.pedhc.2006.07.002_bib8","series-title":"Genital HPV infection fact sheet","year":"2006"},{"issue":"52","key":"10.1016\/j.pedhc.2006.07.002_bib9","first-page":"Q1","article-title":"Recommended childhood and adolescent immunization schedule--United States, 2006","volume":"54","year":"2006","journal-title":"MMWR Weekly"},{"key":"10.1016\/j.pedhc.2006.07.002_bib10","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.pcl.2005.03.001","article-title":"Immunizations in the United States: A rite of passage","volume":"52","author":"Cohen","year":"2005","journal-title":"Pediatric Clinics of North America"},{"key":"10.1016\/j.pedhc.2006.07.002_bib11","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1542\/peds.2005-3038","article-title":"Policy statement: Prevention of pertussis among adolescents: Recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine","volume":"117","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedhc.2006.07.002_bib12","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1542\/peds.2005-1381","article-title":"Factors that are associated with parental acceptance of human papillomavirus vaccines: A randomized intervention study of written information about HPV","volume":"117","author":"Dempsey","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedhc.2006.07.002_bib12a","series-title":"FDA licenses quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil) for the prevention of cervical cancer and other diseases in females caused by human papillomavirus. FDA Center for Drug Evaluation and Research","year":"2006"},{"key":"10.1016\/j.pedhc.2006.07.002_bib12b","series-title":"Product approval information: Licensing action. FDA Center for Drug Evaluation and Research","year":"2006"},{"key":"10.1016\/j.pedhc.2006.07.002_bib13","author":"Guinto-Oampo","year":"2006","journal-title":"Pertussis"},{"key":"10.1016\/j.pedhc.2006.07.002_bib14","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomized controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pedhc.2006.07.002_bib15","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomized control trial","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet"},{"issue":"Suppl.","key":"10.1016\/j.pedhc.2006.07.002_bib16","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1097\/01.inf.0000166161.12087.94","article-title":"Challenges to vaccinating adolescents-Vaccine implementation issues","volume":"24","author":"Humiston","year":"2005","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1016\/j.pedhc.2006.07.002_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.inf.0000195626.35239.58","article-title":"Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children","volume":"25","author":"Knuf","year":"2006","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1016\/j.pedhc.2006.07.002_bib18","first-page":"1839","article-title":"Practice guidelines: ACIP updates recommendations for prevention of hepatitis B virus transmission","volume":"73","author":"Morantz","year":"2006","journal-title":"American Family Physician"},{"key":"10.1016\/j.pedhc.2006.07.002_bib19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa042271","article-title":"Decline in mortality due to varicella after implementation of varicella vaccination in the United States","volume":"352","author":"Nguyen","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pedhc.2006.07.002_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0264-410X(02)00459-0","article-title":"Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine","volume":"21","author":"Nolan","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.pedhc.2006.07.002_bib21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jadohealth.2005.05.016","article-title":"Parental acceptance of the human papillomavirus vaccine","volume":"37","author":"Olshen","year":"2005","journal-title":"Journal of Adolescent Health"},{"key":"10.1016\/j.pedhc.2006.07.002_bib22","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/01.inf.0000172901.29621.e9","article-title":"Dose-response study of a quadrivalent measles, mumps, rubella, and varicella vaccine in healthy children","volume":"24","author":"Shinefield","year":"2005","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1016\/j.pedhc.2006.07.002_bib23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.inf.0000172902.25009.a1","article-title":"Evaluation of a quadrivalent measles, mumps, rubella, and varicella vaccine in healthy children","volume":"24","author":"Shinefield","year":"2005","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1016\/j.pedhc.2006.07.002_bib24","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00006454-200206000-00014","article-title":"Vaccination with measles, mumps, and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody, and duration of protection against varicella in healthy children","volume":"21","author":"Shinefield","year":"2002","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1016\/j.pedhc.2006.07.002_bib25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6,11,16,and 18) L1 virus-like particle vaccine in young women: A randomized double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncology"},{"key":"10.1016\/j.pedhc.2006.07.002_bib26","first-page":"531","article-title":"Strategies for the prevention of cervical cancer by human papillomavirus vaccination","volume":"19","author":"Williamson","year":"2005","journal-title":"Clinical Obstetrics & Gynecology"},{"key":"10.1016\/j.pedhc.2006.07.002_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.idc.2006.01.004","article-title":"Hepatitis B vaccines","volume":"20","author":"Yu","year":"2006","journal-title":"Infectious Disease Clinics of North America"},{"key":"10.1016\/j.pedhc.2006.07.002_bib28","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jadohealth.2005.09.010","article-title":"Improving adolescent health: focus on HPV vaccine acceptance","author":"Zimet","year":"2005","journal-title":"Journal of Adolescent Health, 37"}],"container-title":["Journal of Pediatric Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891524506004159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891524506004159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,13]],"date-time":"2019-01-13T08:26:12Z","timestamp":1547367972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891524506004159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0891524506004159"],"URL":"https:\/\/doi.org\/10.1016\/j.pedhc.2006.07.002","relation":{},"ISSN":["0891-5245"],"issn-type":[{"value":"0891-5245","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}